A Phase 3 Randomized Trial Evaluating Alirocumab 300 mg Every 4 Weeks (Q4W) as Monotherapy or Add-On to Statin: ODYSSEY CHOICE I
暂无分享,去创建一个
D. Rader | J. Bergeron | P. Moriarty | G. Langslet | M. Baccara-Dinet | G. Manvelian | E. Roth | Jian Zhao
暂无分享,去创建一个
D. Rader | J. Bergeron | P. Moriarty | G. Langslet | M. Baccara-Dinet | G. Manvelian | E. Roth | Jian Zhao